(Q34062626)

30 July 2017

1 reference

title

Selecting optimal antisense reagents (English)

1 reference

30 July 2017

Sohail M

1

1 reference

PubMed ID

11035195

30 July 2017

Southern EM

series ordinal

2

1 reference

PubMed ID

11035195

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

Advanced Drug Delivery Reviews

30 July 2017

1 reference

30 July 2017

44

1 reference

30 July 2017

23-34

1 reference

30 July 2017

1

1 reference

Selecting effective antisense reagents on combinatorial oligonucleotide arrays

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Arrays of complementary oligonucleotides for analysing the hybridisation behaviour of nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Potent and selective inhibition of gene expression by an antisense heptanucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Searching for the ideal partner

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Theoretical design of antisense RNA structures substantially improves annealing kinetics and efficacy in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

The folding of large RNAs studied by hybridization to arrays of complementary oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Quantitative hybridization kinetics of DNA probes to RNA in solution followed by diffusional fluorescence correlation analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Features in the 5' non-coding sequences of rabbit alpha and beta-globin mRNAs that affect translational efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Anti-sense phosphorothioate oligonucleotides have both specific and non-specific effects on cells containing human papillomavirus type 16

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Ending the message is not so simple

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Tetranucleotide GGGA motif in primary RNA transcripts. Novel target site for antisense design

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Bias in nucleotide composition of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Target site selection for an RNA-cleaving catalytic DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

An in vitro messenger RNA binding assay as a tool for identifying hybridization-competent antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

The use of single-stranded DNA and RNase H to promote quantitative 'hybrid arrest of translation' of mRNA/DNA hybrids in reticulocyte lysate cell-free translations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

A method for screening antisense oligodeoxyribonucleotides effective for mRNA translation-arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Inhibition of human TNF alpha and LT in cell-free extracts and in cell culture by antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Assessment of high-affinity hybridization, RNase H cleavage, and covalent linkage in translation arrest by antisense oligonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Rapid determination and quantitation of the accessibility to native RNAs by antisense oligodeoxynucleotides in murine cell extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

On finding all suboptimal foldings of an RNA molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Implication of RNA structure on antisense oligonucleotide hybridization kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Specific inhibition of expression of a human collagen gene (COL1A1) with modified antisense oligonucleotides. The most effective target sites are clustered in double-stranded regions of the predicted secondary structure for the mRNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Modelling of the three-dimensional architecture of group I catalytic introns based on comparative sequence analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

An interactive framework for RNA secondary structure prediction with a dynamical treatment of constraints.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

1 reference

7 January 2021

Targeting RNA structures by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Molecular interactions on microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Three-Dimensional Tertiary Structure of Yeast Phenylalanine Transfer RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Structure of yeast phenylalanine tRNA at 3 Å resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Oligonucleotide hybridizations on glass supports: a novel linker for oligonucleotide synthesis and hybridization properties of oligonucleotides synthesised in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Biopolymer synthesis on polypropylene supports. I. Oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Protein enhancement of hammerhead ribozyme catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Site specific enzymatic cleavage of RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Sequence-dependent hydrolysis of RNA using modified oligonucleotide splints and RNase H

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Secondary structure in formylmethionine tRNA influences the site-directed cleavage of ribonuclease H using chimeric 2'-O-methyl oligodeoxyribonucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Phosphorothioate oligodeoxynucleotides: antisense or anti-protein?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Proof of mechanism of antisense drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

A rapid in vitro method for obtaining RNA accessibility patterns for complementary DNA probes: correlation with an intracellular pattern and known RNA structures

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

A DNA enzyme that cleaves RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

A general purpose RNA-cleaving DNA enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Construction of a directed hammerhead ribozyme library: towards the identification of optimal target sites for antisense-mediated gene inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

Mapping adenines, guanines, and pyrimidines in RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2800%2900081-8

7 January 2021

10.1016/S0169-409X(00)00081-8

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11035195